Note 11 - Other Assets

12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Other Assets Disclosure [Text Block]

11.  Other Assets:

Mortgages and Other Financing Receivables

The Company has various mortgages and other financing receivables which consist of loans acquired and loans originated by the Company. For a complete listing of the Company’s mortgages and other financing receivables at December 31, 2019, see Financial Statement Schedule IV included in this annual report on Form 10-K.

The following table reconciles mortgage loans and other financing receivables from January 1, 2017 to December 31, 2019 (in thousands):

	2019			2018			2017
Balance at January 1,	$	14,448		$	21,838		$	23,197
Additions:
New mortgage loans		3,750			14,825			-
Additions under existing mortgage loans		48			-			-
Foreign currency translation		-			116			385
Amortization of loan discounts		33			125			112
Deductions:
Loan repayments		(10,136	)		(21,012	)		-
Charge off/foreign currency translation		-			(155	)		(449	)
Collections of principal		(313	)		(1,287	)		(1,405	)
Amortization of loan costs		(1	)		(2	)		(2	)
Balance at December 31,	$	7,829		$	14,448		$	21,838

The Company reviews payment status to identify performing versus non-performing loans. As of December 31, 2019, the Company had a total of seven loans, all of which were identified as performing loans.

Albertsons –

The Company owns 9.48% of the common stock of Albertsons Companies, Inc. ("ACI"), one of the largest food and drug retailers in the United States and accounts for this investment on the cost method. The Company's net investment in ACI is $140.2 million and is included in Other assets on the Company's Consolidated Balance Sheets. As of December 31,2019, there were no identified events or changes in circumstances that may have a significant adverse effect on the fair value of this cost method investment.

Held-for-Sale - 

At December 31, 2018, the Company had two consolidated properties classified as held-for-sale at an aggregate carrying amount of $17.2 million, net of accumulated depreciation of $5.5 million, which are included in Other assets on the Company’s Consolidated Balance Sheets.  The Company’s determination of the fair value of the properties was based upon executed contracts of sale with third parties, which are in excess of the carrying values of the properties. There were no properties held-for-sale at December 31, 2019.